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Abstract
Introduction: Deep brain gray matter (GM) structures are involved in several
neurodegenerative disorders and are affected by aging. In this study, we investi-
gated the potential relationship between levels of brain-derived neurotrophic
factor (BDNF), a putative biomarker of age- and clinically relevant brain dys-
functions, and the presence of structural modifications that were evaluated by
magnetic resonance imaging in six deep GM structures. Methods: Volume
changes and diffusion tensor imaging (DTI) scalars were studied in the thala-
mus, putamen, hippocampus, caudate nucleus, amygdala and pallidum of a
cohort of 120 healthy subjects. The cohort included young (18–39 years old),
adult (40–59 years old) and elderly (60–76 years old) subjects. Results: No cor-
relations were seen in the young and adult cohorts. In the elderly group, we
observed reduced BDNF levels that correlated with increased DTI-based mean
diffusivity occurring in the left hippocampus along with decreased normalized
volume in the left amygdala. Conclusions: These findings suggest that, in
elderly subjects, BDNF may exert regional and lateralized effects that allow the
integrity of two strategic deep GM areas such as the hippocampus and the
amygdala.
Introduction
Changes in deep gray matter (GM) structures, such as the
hippocampus and amygdala, have often been associated
with a variety of behavioral modifications. As these struc-
tures are greatly affected by neurodegeneration and a
major target for aging-related processes (Harman 1991;
Farooqui and Farooqui 2009), a better understanding of
how physiological aging facilitates the neurodegeneration
of these structures is crucial to maximize the efficacy of
preventive and rehabilitative measures.
When studying brain changes that occur with aging or
neurodegenerative processes, it is crucial to choose the
right neuroimaging approach in order to gain the maxi-
mum amount of information from scans. For example,
high-resolution T1-weighted MR images provide anatomi-
cal detail at the macroscopic level, thereby allowing an
effective investigation of age-related volume shrinkage
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processes occurring in cortical and subcortical GM struc-
tures (Pfefferbaum et al. 1994; Good et al. 2001; Fox and
Schott 2004). The same methodological approach can also
help to characterize patterns and rate of progression of
aging-driven brain atrophy. Diffusion tensor imaging
(DTI) is indicated in the study of microarchitecture varia-
tions and for the investigation, with cellular level infer-
ence, of early pathological alterations. The technique
provides important physiological information than cannot
otherwise be obtained by employing conventional MRI
(Basser 1995; Le Bihan 1995; Basser and Pierpaoli 1996).
Quantification of water diffusion in brain tissues with
DTI is indeed a powerful procedure that allows the analy-
sis of white matter (WM) organization and integrity (Pi-
erpaoli et al. 1996). In contrast, since GM is less
organized in orientation than WM, DTI, at least in the
cerebral cortex, becomes less effective when aiming at
analyzing GM structures. However, thanks to the proxim-
ity of coherent WM, deep GM structures can be evaluated
with DTI as these structures exhibit high directionality in
diffusion (Ziyan and Westin 2008). Among DTI parame-
ters, mean diffusivity (MD) is a quantitative measure of
directionally averaged diffusion and has been successfully
employed to study microstructural alterations of deep
GM regions (M€uller et al. 2007; Cherubini et al. 2009;
Piras et al. 2011). Increased MD in the GM is thought to
be linked to enlargement of the extracellular space. MD is
therefore a good indicator of the cytoarchitectural damage
that occurs along with neurodegeneration (Sykova 2004;
Kantarci et al. 2005). In deep GM structures, these
changes may reflect either direct damage or secondary
reactive degeneration following the disruption of connect-
ing WM tracts (O’Sullivan et al., 2004).
In physiological conditions, extracellular water diffu-
sion is influenced by different factors such as the size of
the pores present between cells, integrity of cellular and
axonal structures, and variations in the cell density and
surface (Sykova and Nicholson, 2008; Le Bihan, 2007).
These structural components affect the efficacy of synaptic
and or extrasynaptic transmission (Sykova 2004) and have
a great impact on the overall strength of synaptic func-
tioning and, ultimately, cognitive functions (O’Sullivan
et al., 2004; Cherubini et al. 2009; Piras et al. 2011).
Increased MD values and volume shrinkage are thought
to be the biological underpinnings of the damage of neu-
ronal somata and/or the neuronal loss that occurs in
aging and/or neurodegeneration (Basser 1995).
Thus, the primary difference between volume and dif-
fusivity indices is that volume shrinkage reflects macro-
scopic structural alterations while diffusivity parameters
are more indicative of structural variations occurring at
cellular and molecular levels (Le Bihan 1995). These dif-
ferences highlight the importance of measuring both
parameters when one wants to carefully evaluate altera-
tions taking place in deep GM structures. Although com-
bined evaluation with different MR techniques has
produced a considerable amount of information about
microstructural alterations and atrophy of deep GM
nuclei (Cherubini et al. 2009), previous studies have also
often produced inconsistent and discordant results (Good
et al. 2001; Liu et al. 2003; Szentkuti et al. 2004; Lema^ıtre
et al. 2005; Walhovd et al. 2005) and, in most cases, missed
the subregional localization of the atrophic processes.
In many studies, the neurotrophin brain-derived neu-
rotrophic factor (BDNF) has been indicated as a putative
biomarker for a variety of brain dysfunctions. BDNF and
its receptor tyrosine kinase (TrkB) are highly concentrated
in the hippocampus (Phillips et al. 1990; Wetmore et al.
1990; Murer et al. 2001), a key region involved in the
modulation of cognition and memory (Kang and Schu-
man 1995; Figurov et al. 1996; Stoop and Poo 1996; Pang
et al. 2004; Tanaka et al. 2008). Furthermore, BDNF is
thought to contribute to neurogenesis taking place in the
dentate gyrus (Takahashi et al. 1999; Benraiss et al. 2001;
Pencea et al. 2001). In humans, high BDNF levels have
been linked to enlargements of hippocampal volumes and
enhanced spatial memory performances (Erickson et al.
2010, 2012). Furthermore, decreased BDNF, at the plasma
and serum level, has been associated with behavioral and
cognitive deficits observed in neurodegenerative and psy-
chiatric disorders (Sen et al. 2008; Erickson et al. 2012).
In line with this, Weinstein and colleagues recently found
that higher serum levels of BDNF protect against future
occurrence of dementia and AD (Weinstein et al. 2014).
Of note, it should be underlined that BDNF is also pro-
duced outside the central nervous system (Scarisbrick
et al. 1993; Timmusk et al. 1993) and the trophin is also
stored and released from blood platelets and immune cells
(Yamamoto and Gurney 1990; Kerschensteiner et al. 1999;
Gielen et al. 2003). Given the central role exerted by BDNF
in controlling neural plasticity and cognition, evaluation of
the trophin levels may represent a viable indicator to assess
age-related changes of neuronal well-being as well as a mar-
ker of pathological brain dysfunctions.
Despite growing evidence of a strong relationship
occurring between changes in BDNF levels and corre-
sponding variations of some brain structures, so far no
studies have investigated how changes in the neurotro-
phin levels may affect or relate to structural alterations of
deep GM regions. A recent study, performed on elderly
subjects, measured volumes of deep GM regions along
with BDNF serum levels and evaluated whether age-
related reductions in BDNF were associated with GM vol-
ume loss and memory deficits (Erickson et al. 2010).
Another study showed that, in the elderly, increased hip-
pocampal size is associated with higher BDNF concentra-
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tions (Erickson et al. 2011). Finally, in elderly subjects
who reported cognitive benefits from aerobic training,
evaluation of neuronal activity with functional magnetic
resonance imaging (fMRI) together with analysis of
changes in several neurobiological markers (including
BDNF) indicated that these markers positively relate to
increased levels of brain plasticity (Voss et al. 2013). In
summary, previous brain-aging studies successfully inves-
tigated micro- and macrostructural brain alterations alone
or, alternatively, studied macrostructural changes in con-
junction with variations of serum BDNF levels; however,
so far, no study had evaluated changes simultaneously
occurring at all the three levels.
This study is the first that attempts to overcome the
limitations of previous investigations on effects of aging
in subcortical GM structures. To this aim, in a hypothe-
sis-free fashion, we explored changes in volume, DTI sca-
lars along with evaluation of serum BDNF levels in six
deep GM structures (i.e., thalamus, putamen, hippocam-
pus, caudate nucleus, amygdala, and pallidum) in a
cohort of healthy subjects divided into three age brackets:
young (18–39 years old), middle aged (40–59 years old),
and elderly (60–76 years old) subjects.
Experimental Procedures
Participants
We recruited 120 healthy subjects [47 males (39.1%);
mean age  SD = 40.1  15.3 years, range 18–76; mean
education  SD = 14.6  3.3 years, range 5–24] for the
study. The only inclusion criterion was age between 18
and 80 years. Exclusion criteria encompassed: (1) suspi-
cion of cognitive impairment or dementia based on a
Mini-Mental State Examination [(MMSE) (Folstein et al.
1975)] score lower or equal to 26 consistent with norma-
tive data collected in the Italian population and con-
firmed by a detailed clinical neuropsychological
evaluation using the mental deterioration battery (MDB)
(Carlesimo et al. 1996) and clinical criteria for Alzhei-
mer’s dementia established by the National Institute on
Aging and the Alzheimer’s Association (McKhann et al.
2011), or Mild Cognitive Impairment (Petersen and Mor-
ris 2005), (2) subjective complaint of memory difficulties
or of any other cognitive deficits regardless of whether or
not these interfere with daily living activities, (3) vision
and hearing loss that could potentially interfere with test-
ing procedures, (4) major medical illnesses (i.e., unstable
diabetes, obstructive pulmonary disease, or asthma; hema-
tological and oncological disorders; pernicious anemia;
significant gastrointestinal, renal, hepatic, endocrine, or
cardiovascular system diseases; recently treated hypo-thy-
roidism), (5) current or reported psychiatric (assessed by
the DSM-IV-TR SCID, First et al. 2002) or neurological
(assessed by a clinical neurological evaluation) disorders
(e.g., schizophrenia, mood disorders or anxiety disorders,
stroke, Parkinson’s disease, seizures, head injury with loss
of consciousness, or any other significant mental or neu-
rological condition), (6) known or suspected history of
alcoholism or drug addiction and/or history of abuse, (7)
any potential brain abnormality or microvascular lesion
that was appearing with conventional FLAIR scans; in
particular, the presence, severity, and location of vascular
lesions were, in fact, computed according to the semiau-
tomated method recently published by our group (Iorio
et al. 2013). Finally, all subjects met the criteria for partici-
pation in an MRI study, and therefore had no previous
head or neck surgery, no previous head trauma, no brain
tumors and no metallic implants that could interfere with
or cause injury due to the magnetic field. The cohort
composition by age and gender is summarized in Table 1.
The study was approved and undertaken in accordance
with the guidelines of the Santa Lucia Foundation Ethics
Committee. A written consent form was signed by all par-
ticipants after they received a full explanation of the study
procedures.
Neuropsychological assessment
A neuropsychological test battery was only used to
exclude subjects with dementia or cognitive impairment.
To obtain a global index of cognitive impairment, we
employed the Mini-Mental State examination MMSE
(Folstein et al. 1975). The instrument is brief and easy to
administer and is widely used to screen for cognitive
deterioration. Subjects were also asked to perform the
Multiple Features Targets Cancellation Task (MFTC,
Gainotti et al. 2001), a test that assesses visuospatial
explorative abilities and psychomotor processing speed.
Moreover, we administered the Copy and Delayed Recall
of Rey-Osterrieth’s complex picture test (CROP and
ROPR, respectively; Osterrieth 1944) to evaluate visual
perception/constructional praxis, perceptual organiza-
tional skills, planning, and problem-solving. We also
chose three tests from the mental deterioration battery
(MDB, Carlesimo et al. 1996) to provide information
about functioning of different cognitive domains such as
verbal memory (MDB Rey’s 15-word Immediate Recall
Table 1. Sociodemographic characteristics of 120 healthy subjects
separated by age.
Age 18–39 40–59 60–76
Number 67 33 20
Gender male, n (%) 29 (43.2) 11 (33.3) 7 (35)
Years of Education,
mean  Standard Deviation
15.9  2.6 14.0  2.7 11.0  3.6
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[RIR] and Delayed Recall [RDR]), logical reasoning
(MDB Raven’s Progressive Matrices’ 47 [PM47]), lan-
guage (MDB Phonological (PVF), and Semantic (SVF)
Verbal Fluency). Finally, set-shifting or cognitive flexibil-
ity was assessed using the Modified Wisconsin Card Sort-
ing Test (MWCST; Heaton et al. 1993).
Image acquisition
All 120 participants underwent the same MR imaging
protocol, which included acquisition of standard clinical
sequences (Fluid Attenuated Inversion Recovery (FLAIR)
and PD-T2-weighted), whole-brain T1-weighted, and dif-
fusion-weighted scanning using a 3T Allegra MR imager
(Siemens, Erlangen, Germany), equipped with a standard
quadrature head coil. All planar sequences were acquired
along the anterior/posterior commissure line. Particular
care was taken to center the subject’s head in the head
coil and to restrain movements using cushions. Whole-
brain T1-weighted images were acquired in the sagittal
plane using a modified driven equilibrium Fourier trans-
form (MDEFT) sequence (TE/TR = 2.4/7.92 ms, flip
angle = 15°, voxel size = 1 9 1 9 1 mm3). The echo-pla-
nar imaging technique (spin-echo-planar imaging, TE/
TR = 89/8500 ms, bandwidth = 2126 Hz/vx; matrix
size = 128 9 128; 80 axial slices, voxel size = 1.8 9
1.8 9 1.8 mm3) was used to collect diffusion-weighted
volumes, with 30 isotropically distributed orientations for
the diffusion-sensitizing gradients at a b-value of 1000
smm2 and six b = 0 images. Scanning was repeated three
times to increase the signal-to-noise ratio.
Image processing
Whole-image processing was performed using the Oxford
Centre for Functional MRI of the Brain (FMRIB)’s Soft-
ware Library (FSL, http://www.fmrib.ox.ac.uk/fsl/), ver-
sion 4.1.
The FMRIB’s Integrated Registration and Segmentation
Tool (FIRST), included in FSL, was used for segmentation
and volumetric analysis of the anatomical T1-weighted
images. FIRST is a semiautomated model-based subcorti-
cal segmentation/registration tool that employes a Bayes-
ian approach. The shape/appearance models used in
FIRST are constructed from manually segmented images
provided by the Center for Morphometric Analysis
(CMA), MGH, Boston, MA, USA. The manual labels are
parameterized as surface meshes and modeled as a point
distribution model in which the geometry and variation
of the shape of the structure are submitted as priors.
Deformable surfaces are used to automatically parameter-
ize the volumetric labels in terms of meshes; the deform-
able surfaces are constrained to preserve vertex
correspondence across the training data. Furthermore,
normalized intensities along the surface normals are sam-
pled and modeled. The shape and appearance model is
based on multivariate Gaussian assumptions. Shape is
then expressed as a mean with modes of variation (princi-
pal components). On the basis of the learned models,
FIRST searches through linear combinations of shape
modes of variation for the most probable shape instance
given the intensity distribution in the T1-weighted image.
Particularly useful for structures with a low contrast-
to-noise ratio, this method of segmentation makes the
FIRST tool the best for finding the optimal border and
extent of the structures considered, modeling these
structures as surfaces.
DTI data were corrected for image distortions induced
by eddy currents and head motion by applying 3D full
affine (mutual information cost function) alignment of
each image to the mean no diffusion-weighted (b0) image.
After these corrections, DTI data were averaged and con-
catenated into 31 (1 b0 + 30 b1000) volumes. A diffusion
tensor model was fit at each voxel, generating fractional
anisotropy (FA) and MD maps. The FA maps were useful
for obtaining a better coregistration with T1-weighted
images (because the spatial distribution of signal intensities
was similar in both image modalities), whereas MD values
were used as an index of microstructural integrity within
the deep gray matter nuclei. The FA maps created were
registered to the whole-brain volumes extracted from T1-
weighted images using a full affine (correlation ratio cost
function) alignment with nearest-neighbor resampling.
The calculated transformation matrix was applied to the
MD maps with identical resampling options.
For each subject and each hemisphere, the procedure
was as follows: (1) the caudate (body), putamen, palli-
dum, thalamus (thalamic nuclei and pulvinar), hippocam-
pus (dentate gyrus, cornus ammonis (CA1, CA2, CA3,
CA4), presubiculum and subiculum), and amygdala (ba-
solateral complex, centro-medial and cortical nuclei) were
segmented; (2) The resulting region-of-interest (ROI) seg-
mentation and the coregistered FA map were then super-
imposed on the original T1-weighted volumes; (3) the
obtained images were visually assessed by two trained
radiologists to exclude misregistration or erroneous ROI
identification; (4) finally, the volumes of the above-men-
tioned ROIs were calculated. Before statistical analysis,
individual volume values were multiplied by a normaliza-
tion factor obtained with the SIENAX tool (Smith et al.
2001) from the corresponding T1-weighted image. These
segmented ROIs defined the binary masks where mean
values of MD were calculated for each individual and
each hemisphere. Previous studies used this method suc-
cessfully for image processing (Cherubini et al. 2009;
Piras et al. 2010, 2011).
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Blood serum collection and analysis
Venous blood was drawn from all subjects after an over-
night fast. Within two hours from collection, serum was
obtained after centrifugation of clotted blood samples,
distributed into aliquots and stored at 80 °C until fur-
ther analysis.
BDNF was detected in serum samples by sandwich
ELISA according to the manufacturer’s instructions (Duo-
Set ELISA, R&D Systems, Minneapolis, MN, USA).
Briefly, 96-well immunoassay plates were coated overnight
with 100 lL/well of mouse anti-human BDNF monoclo-
nal antibody (working concentration 2 lg/mL) at room
temperature (RT). Plates were then washed and blocked
with assay buffer (PBS/BSA 1%) for 1 hour. After further
washing, 100 lL/well of serum samples (diluted 1:40) and
serial dilutions of the BDNF standard (ranging from 23.4
to 1500 pg/mL BDNF) were incubated for 2 hours at RT.
Plates were washed and 100 lL of biotinylated mouse
anti-human BDNF monoclonal antibody (working con-
centration 25 ng/mL) were added to each well and incu-
bated for two hours at RT. After washing, 100 lL/well of
a streptavidin-enzyme conjugate (diluted 1:200) was
added and incubated for 20 min at RT. After further
washing, 100 lL/well of a substrate solution (Tetrameth-
ylbenzide, Sigma, Saint Louis, MO, USA) was added to
the wells to initiate a reaction, which was stopped after
30 min by adding 100 lL/well of a stop solution (HCl
1M). The amount of BDNF was determined immediately
by measuring absorbance at 450 nm using a microplate
reader. The standard curve demonstrated a direct rela-
tionship between optical density and BDNF concentra-
tion. BDNF content was quantified against the standard
curve. The detection limit was <4 pg/mL. Measurements
were performed in duplicate and expressed as pg/mL. No
cross-reactivity with other related neurotrophins (NGF,
GDNF, NT-3; NT-4) was reported.
Serum (rather than plasma) was examined for two
main reasons: (1) to avoid confounding results due to
BDNF contained in platelets and released by platelet acti-
vation; (2) because it is the most commonly employed
method to investigate relationships between changes in
blood growth factors and individual differences in neuro-
psychiatric, cognitive, and exercise-driven variations
occurring in humans (e.g., see review Brunoni et al.
2008).
Statistical Analysis
Briefly, preliminary correlation analyses were conducted
with the aim of selecting the variables to include in the
multiple regression analysis; then, to evaluate the rele-
vance, relative contribution and rate of change of these
parameters with BDNF, multivariate procedures were run,
with the BDNF values entered as dependent variable and
the anatomical measures or the neuropsychological scores
that survived the P < 0.05 threshold in the univariate cor-
relation analyses as independent variables (quantitative
predictors).
In particular, data from all 120 subjects were included
in the statistical investigation and analyses were run sepa-
rately by three age brackets (young, adult and elderly
subjects). To investigate the association between changes
in BDNF and micro- and macrostructural variations of
six deep GM structures mean MD and volume values
were considered as regressors.
First, we calculated partial correlation coefficients
(Pearson’s r) between BDNF and each of these parameters
in the single ROIs. The analysis was separated by age cat-
egory to assess the relationship between BDNF and: (1)
micro-(MD) and (2) macro-(volume) anatomical mea-
sures. To approximate the strength of the difference
between group correlation values, Fisher’s r-to-Z transfor-
mation was carried out to compare the magnitude of the
partial correlations. Since a high number of correlation
analyses can increase the risk of a type I error (thereby
leading to erroneously inferring the presence of a signifi-
cant correlation) if calculated individually, the relation-
ship between BDNF levels, volumetry, and MD variables
was further assessed by means of a stepwise multiple
regression analysis, that is, a multivariate statistical model
which permits studying relationships without inflating the
risk of a type I error (Draper and Smith 1981). This
method of regression is a data-driven automatic proce-
dure for statistical model selection in cases in which there
are a large number of potential explanatory variables and
no underlying theory for the model selection. We chose
to perform both forward and backward stepwise regres-
sions by considering all independent variables jointly. The
forward selection approach starts with no variables in the
model, tests the addition of each variable using a chosen
model comparison criterion (statistically significant vari-
able), adds the variable (if any) that improves the model
most, and repeats this process until adding another vari-
able does not improve the model; inversely, the backward
elimination technique starts with all candidate variables,
tests the deletion of each variable using a chosen model
comparison criterion, deletes the variable (if any) that
improves the model most by being deleted, and repeats
this process until no further improvement is possible
(Derksen and Keselman 1992). Results that are found
valid by both procedures (forward and backward) are
eventually taken in account. Finally, because of the possi-
ble multicollinearity between neuroimaging variables,
which impacts conclusions about the significance of effect
model applicability in regression model, we checked the
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tolerance value of each variable predictor, that is propor-
tion of variation in each predictor independent from the
correlation between regressors (Berk 1977). The tolerance
value was computed as: (1Rj²), where Rj² is the coeffi-
cient of determination obtained by modeling the jth
regressor as a linear function of the remaining indepen-
dent variables. The cut-off value was set such that the
variability in a predictor not related to other variables in
the model was at least larger than 30%.
Results
Preliminary correlation analyses: BDNF
levels and changes in volumetric and DTI
Data
As shown in Table 2, in the elderly subgroup BDNF levels
correlated: (1) positively with normalized volume (NV)
and MD of the left amygdala, and (2) negatively with
bilateral hippocampus MD.
An ancillary result was found in the young subgroup,
where the normalized volume of the right caudate nucleus
positively correlated with BDNF levels.
When we further explored the relationship occurring
between the amygdala and the hippocampus macromicro-
structural parameters by a two-by-two approach or
between each of them and age, strong positive correla-
tions appeared, only in the elderly subject group, between:
(1) NV of the left amygdala and age (r=0.543;
P-value=0.012), (2) MD and NV of the left amygdala
(r=0.59; P-value=0.0208); and (3) MD of the left and right
hippocampus (r=0.611; P-value= 0.0034) (see Table 3).
Finally, a number of significant anticorrelations
emerged, in the whole cohort of 120 subjects, between:
(1) the MD of the left hippocampus and education levels
(r = 0.260; P-value = 0.0039), (2) the MD of the right
hippocampus and education levels (r = 0.290;
P-value = 0.0012), and (3) subject education levels and
their age (r = 0.454; P-value <0.0001).
Stepwise multiple regression analyses
Before running the stepwise multiple regression analyses,
we computed the tolerance value for each variable signifi-
cantly associated with BDNF values, in order to control
for multicollinearity among variables. Such value was
above the 0.30 cut-off for all variables (i.e., 0.974 for NV
of left amygdala, 0.987 for MD of left amygdala, 0.482 for
MD of right hippocampus, and 0.483 for MD of left hip-
pocampus). Therefore, these variables could be included
in the following multivariate regression model.
For the initial forward stepwise regression analysis, we
evaluated all the quantitative variables that emerged
Table 2. Crude correlations between BDNF value and volumetric
data, DTI data of 120 healthy subjects separated by age. Significant
P-values are starred.
Normalized volume Mean diffusivity
Pearson’s r P-value Pearson’s r P-value
Young group
Left Amygdala 0.121 0.3316 0.008 0.9461
Left Caudate Nucleus 0.130 0.2951 0.162 0.1923
Left Hippocampus 0.003 0.9830 0.046 0.7137
Left Globus Pallidus 0.081 0.5135 0.007 0.9538
Left Putamen 0.003 0.9840 0.070 0.5768
Left Thalamus 0.148 0.2333 0.033 0.7926
Right Amygdala 0.142 0.2511 0.028 0.8249
Right Caudate Nucleus 0.355 0.0030* 0.002 0.9849
Right Hippocampus 0.051 0.6819 0.119 0.3373
Right Globus Pallidus 0.001 0.9907 0.007 0.9577
Right Putamen 0.013 0.9183 0.042 0.7390
Right Thalamus 0.098 0.4301 0.025 0.8390
Adult group
Left Amygdala 0.055 0.7648 0.199 0.2684
Left Caudate Nucleus 0.066 0.7179 0.070 0.7021
Left Hippocampus 0.057 0.7546 0.039 0.8301
Left Globus Pallidus 0.115 0.5265 0.067 0.7136
Left Putamen 0.231 0.1974 0.017 0.9252
Left Thalamus 0.163 0.3675 0.063 0.7297
Right Amygdala 0.149 0.4099 0.044 0.8097
Right Caudate Nucleus 0.112 0.5383 0.168 0.3542
Right Hippocampus 0.070 0.7010 0.020 0.9110
Right Globus Pallidus 0.043 0.8133 0.086 0.6350
Right Putamen 0.208 0.2472 0.094 0.6041
Right Thalamus 0.239 0.1828 0.087 0.6335
Elderly group
Left Amygdala 0.573 0.0072* 0.510 0.0202*
Left Caudate Nucleus 0.054 0.8244 0.273 0.2485
Left Hippocampus 0.253 0.2866 0.520 0.0174*
Left Globus Pallidus 0.292 0.2147 0.006 0.9787
Left Putamen 0.076 0.7535 0.066 0.7868
Left Thalamus 0.222 0.3514 0.222 0.3511
Right Amygdala 0.045 0.8536 0.381 0.0976
Right Caudate Nucleus 0.241 0.3110 0.350 0.1325
Right Hippocampus 0.234 0.3249 0.469 0.0360*
Right Globus Pallidus 0.363 0.1171 0.252 0.2889
Right Putamen 0.253 0.2859 0.165 0.4923
Right Thalamus 0.231 0.3324 0.106 0.6596
Table 3. Additional correlations in the elderly group.
Variables involved Results
Variable 1 Variable 2 Pearson’s r P-value
NV of the left
amygdala
Age 0.543 0.0120
MD of the left
amygdala
NV of the left
amygdala
0.509 0.0208
MD of the right
hippocampus
MD of the left
hippocampus
0.611 0.0034
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from the preliminary correlation analyses (NV and MD
of left amygdala, MD of the left and right hippocampi)
and matched these results with BDNF levels (considered
as dependent variable). The only micro- and macro-
structural values that entered into the regression model
(as expected from the partial preliminary correlation and
the statistical significance found only in the elderly
group) were the NV of the left amygdala and the MD
of the left hippocampus. In particular, increased BDNF
values were related to increased NV of the left amygdala
(beta = 0.560) and to decreased MD of the left hippo-
campus (beta = 0.506) (see Table 4). No other vari-
ables reached the statistical threshold to fit the model
(i.e., the remaining two factors did not act as significant
predictors of BDNF levels). The equation was significant
for F = 11.937; df = 2; P < 0.001; adjusted R2 = 0.535,
and explained 53.5% of the overall variance of the
dependent variable. Scatter plots showing positive and
negative correlations between BDNF levels and: (1) NV
of the left amygdala and (2) MD of the left hippocam-
pus are shown in Figure 1. These results were fully con-
firmed by the backward stepwise regression model in
which the surviving variables were identical to those
reported for the forward procedure.
Discussion
In a large cohort of healthy subjects clustered into three
age groups, we investigated the relationship between levels
of BDNF, a clinically relevant putative biomarker of
aging, and modifications in six deep GM brain structures
analyzed with quantitative MR parameters. This dataset
was complemented with sociodemographic data. The
main finding of the study is that, in the elderly popula-
tion (age bracket: 60–76 years old), increased MD of the
left hippocampus and decreased NV of the left amygdala
were significantly associated with decreased BDNF periph-
eral levels.
The shrinkage of the hippocampal region (even if at a
microstructural MD level) along with the reduced BDNF
levels that we found in the elderly is in accordance with
the known physiological role of the neurotrophin in
maintaining hippocampal structure. Using an exploratory
mediation analysis, Erickson et al. (Erickson et al. 2010)
recently highlighted that BDNF modulates age-related
decrease of hippocampal volume, a phenomenon that has
functional consequences in terms of decay of spatial
memory performances. One can speculate that the hippo-
campal MD increase that we have found in association
with decreased BDNF levels may be an index of decreased
synaptogenesis and enlargement of the extracellular space
due to altered cytoarchitecture, thereby suggesting imma-
turity or early degeneration of the tissue (Sykova 2004;
Kantarci et al. 2005).
As for the NV of the left amygdala, the positive corre-
lation we found with BDNF serum level offers several
possible interpretations. Since BDNF signaling seems
particularly important in promoting amygdala-dependent
LTP and can favor the acquisition and consolidation of
appetitive and aversive learning events (Heldt et al.
2014), BDNF serum levels and changes in the left amyg-
dala volume can be seen as potential risk factors for
affective disorders associated with aging in the elderly
(Wolf et al. 2013). Given the role of this brain region in
the encoding of positive or negative information of any
given event, the phenomenon can also translate in
BDNF-dependent modulation of the handling of emo-
tional content of memory encoding (Soliman et al. 2010;
van Wingen et al. 2010). For example, changes in amyg-
dala volume have been correlated quite specifically with
bipolar disorders. In this regard, a recent study compar-
ing hippocampal and amygdala volumes in two age-
matched groups of elderly bipolar patients and control
subjects found smaller volumes in the left amygdala of
patients (Wijeratne et al. 2013). A positive association
between amygdala volume and anxiety traits has also
been described in healthy individuals (Barros-Loscertales
et al. 2006; van der Plas et al. 2010; Tottenham et al.
2010; Gerritsen et al. 2012).
Interestingly, we found a lateralization effect in the left
hemisphere. Previous studies showed asymmetries in vol-
ume and function of the left and right hippocampus and
suggested that the two hemispheres may play different
but complementary roles in the modulation of memory
tasks that are driven by speed (Erickson et al. 2009).
Other studies that associated age-related reductions in
Table 4. Forward multiple regression analysis of BDNF, using micro-
and macrobrain structural quantitative variables, for 20 healthy elderly
subjects. For each step of the automated procedures, beta standard
coefficient and relative P-values for variables reaching the statistical
threshold to enter into the model equation are indicated.
Variable
Forward analysis
Step 1 Step 2 Step 3
NV of the left amygdala 0.573 (0.008) 0.560 (0.002)
MD of the left
hippocampus
– 0.506 (0.005)
MD of the right
hippocampus
– –
MD of the left
amygdala
– –
Adjusted R2 0.291 0.535
F 8.798 11.937
Significance <0.008 <0.001
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BDNF levels with shrinkage of the hippocampi (Erickson
et al. 2010, 2011) found more specific changes. These
changes were occurring only in the left hippocampus,
with decreased MD that negatively correlated with BDNF
levels, and in the left amygdala, where volume increase
positively correlated with BDNF levels. The mechanisms
underlying the asymmetric shrinkage that we have
observed in our elderly individuals definitely need further
investigation although one can, again, speculate that neu-
rotrophin demands are nor equally distributed between
the two hippocampi or amygdala and, perhaps, these two
structures of the dominant hemisphere show higher needs
and suffers, prematurely, from early BDNF decreases.
Our study lends support to the assumption that MD
seems to be a better parameter for investigating neurode-
generative changes occurring in the early stages or even in
healthy individuals. In this context, the MD increase in
the left hippocampus, which we found associated with
BDNF reductions, further suggests that the parameter
may be a reliable indicator of changes leading to cell loss
and impaired structural integrity. Furthermore, in a
recent study based on the Alzheimer’s disease neuroimag-
ing initiative (ADNI) database (adni.loni.ucla.edu), a dis-
criminant analysis combining shape information of
selected subcortical structures resulted in improved sensi-
tivity and specificity. The authors implemented a fine
characterization of atrophy patterns in the amygdala and
hippocampus by integrating high-field imaging techniques
and ran a Linear Discriminant Analysis (LDA) aimed at
building the best LDA classifier based on shape informa-
tion of seven structures and estimating the true classifica-
tion rate derivable from the classification procedure.
Results of the study corroborated our findings on the
amygdala–hippocampal complex. Of the seven structures
analyzed, the hippocampus exhibited the highest discrimi-
native capacity; moreover, the optimal LDA originated
from a combination of three structures: the hippocampus,
amygdala, and lateral ventricle. When were compared
individuals with mild cognitive impairment (MCI) and
those with MCI who converted to AD, the authors found
group surface differences primarily in these structures and
detected variations in other subcortical areas. Finally, by
transferring the subregions from a 0.8 mm isotropic 7.0T
MR scan onto their template surfaces, the authors were
able to pin down the most pronounced atrophic process
to the CA1 hippocampal subregion in MCI and AD
patients (Markesbery et al. 2006).
Our findings in healthy elderly individuals suggest that
integrating structural information on the morphological
status of several deep brain GM structures can be very
helpful, in prospect, when trying to decipher the specific
atrophy patterns that may take place in important and
widespread neurodegenerative conditions like Alzheimer’s
disease (AD). For instance, a more accurate evaluation of
microstructural and subregional changes can be very
important and one should always keep in mind that the
Figure 1. Relationship between BDNF
levels and brain macro- and microstructural
indices. Scatterplots show the association
between BDNF levels and the left amygdala
normalized volume (NV) (green) and left
hippocampus mean diffusivity (MD, red).
Linear fit (dotted lines) is reported.
Brain and Behavior, doi: 10.1002/brb3.334 (8 of 11) ª 2015 The Authors. Brain and Behavior published by Wiley Periodicals, Inc.
Hippocampus–Amygdala Structure and BDNF in Healthy Individuals A. Manna et al.
evaluation, as a whole, of volume modifications of any
single anatomical structure often does not provide crucial
information about the changes taking place at subregional
levels. Still with a net result of no changes in the whole
structure, some subregions may, in fact, develop atrophy
that is masked by others that could have expanded. Com-
bining BDNF levels with analysis of MD and NV can pro-
vide a more specific roadmap of the neurodegenerative
pathways taken by the aging brain and AD.
We are aware that this study has some limitations. The
primary one is the relatively small sample of elderly sub-
jects, a factor that affected the strength of the correlations
as well as the statistical power. Thus, results of this study
warrant further investigation to definitively confirm the
interplay between BDNF and lateralized amygdala–hippo-
campal plasticity in a larger cohort of elderly subjects.
Nevertheless, we here describe an age-related association
between presence of NV reduction in the left amygdala,
MD increase in the left hippocampus, and reduce serum
BDNF levels, thereby lending support to the idea that the
neurotrophin may exert beneficial neural plasticity effect
aimed at maintaining the structural integrity of these two
critically important brain structures.
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